Ted Sorom, CEO and co-founder of Mantle, is looking to revolutionize metal 3D printing. Mantle has a paste extrusion method that features a post-machining step to mill unfinished parts and achieve better results. The paste is unique in that results in parts that harder than green components made using metal binder jet, which are likely to collapse under their own weight. Mantle’s parts can then be machined, making them ideally suited for end use. Less finishing, less post-processing, fewer supports, better surface quality, and lower costs could be a result. Rather than present its technology as the end-all-be-all of all metal 3D printing, Mantle is, for now, targeting tooling alone. This tight focus accelerates the firm’s go-to market. This was really an interesting chat and we hope that you enjoy it.
Podcast (podcast-audio): Play in new window | Download
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
Stanford’s Dr. Skylar-Scott Breaks Down the Timeline for Fully Bioprinted Organs
Bioprinting has transitioned from an ambitious idea to a field making steady progress toward creating functional tissues and vascularized structures, offering a glimpse into the future of regenerative medicine. Against...
Can 3D Printing with Captured Carbon Help Address Climate Change?
It sounds almost too good to be true, but a recent study published in Nature Communications describes a potentially groundbreaking process where carbon dioxide (CO2) is converted into 3D-printed carbon...
American Axle & Manufacturing Acquires GKN Powder Metallurgy and GKN Automotive for $1.44B
American Axle & Manufacturing (AAM), a publicly listed supplier of automotive driveline and drivetrain components headquartered in Detroit, has acquired Dowlais Group plc, the parent company of GKN Automotive and...
Stanford’s $250 Bioprinter Makes Bioprinting Accessible to All
Bioprinting has long been praised as a groundbreaking tool for advancing regenerative medicine, drug testing, and tissue engineering. But despite its immense potential, the high cost of bioprinters has kept...